Microbiota alterations in patients treated for susceptible or drug-resistant TB
Second-line anti-TB therapy in participants with DR-TB results in altered microbiota, including reduced alpha diversity and expansion of phylogenetically diverse taxa, including pathobionts.
Authors
- Ulrich E. Schaible (ORCID: https://orcid.org/0000-0002-6638-7282)
- Barbara Kalsdorf
- Matthias Hauptmann (ORCID: https://orcid.org/0000-0002-4710-6502)
- C. C. Lange (ORCID: https://orcid.org/0000-0002-8334-1884)
- J.E. Akoh-Arrey
Institutions
- Baylor College of Medicine (US)
- German Center for Infection Research (DE)
- Research Center Borstel - Leibniz Lung Center (DE)
- Pulmonary Associates (US)
- Texas Children's Hospital (US)
- University of Lübeck (DE)
Publication Details
- Journal
- IJTLD OPEN
- Published
- 2024-08-01
- DOI
- https://doi.org/10.5588/ijtldopen.24.0325
- Citations
- 2
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.78
Funders
- Deutsches Zentrum für Infektionsforschung
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Exzellenzclusters Entzündungsforschung
- Leibniz-Gemeinschaft